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GLI1E1/4-qF 5'-GCGCCCAGACAGAGGCCCACT GLI1E3-qF 5'-CCACAGTTATGGGCCAGCCAGAGAG GLI1E4-qR 5'-GGCATCCGACAGAGGTGAGATGGAC RPLP0-qF 5'-CCTTCTCCTTTGGGCTGGTCATCCA RPLP0-qR 5'-CAGACACTGGCAACATTGCGGACAC HPRT1-qF 5'-TGCAGACTTTGCTTTCCTTGGTCAGG HPRT1-qR 5'-CCAACACTTCGTGGGGTCCTTTTCA GAPDH-qF 5'-CTTCGCTCTCTGCTCCTCCTGTTCG GAPDH-qR
Supplemental figure 1. Western blot analysis of GLI1 isoform expression. SAG-treated Daoy-EGFP cells, the RMS13 cell line and transfected Hek293 cells with FLAG-tagged expression constructs of GLI1FL or GLI1∆N (see Experimental Procedures) were used. Arrows indicate the GLI1 isoforms. Molecular weight markers are also shown.
Supplemental figure 2. Comparison of the luciferase activity of the FLAG-tagged pCMV5 constructs of GLI1∆N and GLI1FL in C3H10T1/2 cell lines. Fifty ng of the constructs were co-transfected with 12xGLIBS-luc and pRL-SV reporter plasmids into C3H10T1/2 cells. The luciferase activity was measured at days 1 and 2 after transfection. The error bars indicate the standard deviation. The differences between the GLI1FL and GLI1∆N values were statistically significant (P < 0.001, ANOVA -Bonferroni test).
Supplemental figure 3. Inhibition of GLI1∆N and GLI1FL activity by the PTCH1 variants and PTCH2. Fifty ng of the FLAG-tagged GLI1∆N or GLI1FL constructs in pCMV5 were co-transfected with 25 or 100 ng of PTCH2, PTCH1-1 or PTCH1-1C expression constructs, and the luciferase activity of the 12xGLIBS-luc reporter was measured. The error bars indicate the standard deviation. The differences between the GLI1FL and GLI1∆N values were not statistically significant (ANOVA -Bonferroni test).
Supplemental figure 4. Cytoplasmic localization of GLI1FL and GLI1∆N in the presence of PTCH1. NIH3T3 cells were co-transfected with 200 ng of the Myc-tagged PCTH1-1B (red signal) and 100 ng of the GLI1 constructs or a pCMV5 empty vector. The red scale bars represent 20 µm.
Supplemental figure 5. Subcellular localization of the EGFP-tagged GLI1 isoforms. NIH3T3 cells were transfected with 100 ng of the EGFP-tagged GLI1FL and GLI1∆N constructs or the pEGFP empty vector. Expressed proteins (green signal) and nuclei stained with the DRAQ5 (blue signal) were visualized by immunofluorescence microscopy. The red scale bars represent 20 µm.
Supplemental figure 6. Subcellular localization of the FLAG-tagged GLI1 isoforms co-transfected with Dyrk1 constructs. FLAG-tagged GLI1 constructs (100 ng) were co-transfected with 200 ng of Dyrk1WT (A) or Dyrk1KR (B) constructs into NIH3T3 cells. Expressed GLI1 (green signal) and Dyrk1 (red signal) proteins and nuclei stained with the DRAQ5 (blue signal) were visualized by immunofluorescence microscopy. The red scale bars represent 20 µm.
Supplemental figure 7. Subcellular localization of the EGFP-tagged GLI1 isoforms co-transfected with Dyrk1 constructs. EGFP-tagged GLI1 constructs (100 ng) were co-transfected with 200 ng of Dyrk1WT (A) or Dyrk1KR (B) constructs into NIH3T3 cells. Expressed GLI1 protein (green signal) and nuclei stained with the DRAQ5 (blue signal) were visualized by immunofluorescence microscopy. The red scale bars represent 20 µm.
